AI Article Synopsis
- The Society for Palliative Radiation Oncology (SPRO) aims to improve palliative radiation therapy through research, education, collaboration, and patient advocacy.
- Their 9th Annual Meeting took place on October 23, 2022, alongside the American Society for Radiation Oncology's 64th Annual Meeting, focusing on achievements and future goals.
- Dr. Dirk Rades delivered the keynote address on stereotactic body radiotherapy (SBRT); the meeting also featured the announcement of award recipients and new officers.
Article Abstract
The Society for Palliative Radiation Oncology (SPRO) is an international group of clinicians whose primary aim is to advance the field of palliative radiation oncology by promoting evidence-based palliative radiation therapy and excellence in primary palliative care through research, education, collaboration, and patient advocacy. SPRO held its 9th Annual Meeting on October 23, 2022 in association with the American Society for Radiation Oncology (ASTRO) 64th Annual Meeting. Accomplishments and goals from the previous year were discussed and newly appointed officers were announced. Dr. Dirk Rades from the University of Lubeck in Germany gave the keynote address, reviewing critical trials and evidence for the use of stereotactic body radiotherapy (SBRT) in the palliative and oligometastatic settings. Recipients of the Lifetime Service Award and the Rising Star Award were announced and presented. This Meeting Report summarizes the proceedings of SPRO's 9th Annual Meeting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21037/apm-22-1430 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of decision-making with locally run and web-based large language models versus human board recommendations in otorhinolaryngology, head and neck surgery.
Eur Arch Otorhinolaryngol
January 2025
Department of Otorhinolaryngology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.
Introduction: Tumor boards are a cornerstone of modern cancer treatment. Given their advanced capabilities, the role of Large Language Models (LLMs) in generating tumor board decisions for otorhinolaryngology (ORL) head and neck surgery is gaining increasing attention. However, concerns over data protection and the use of confidential patient information in web-based LLMs have restricted their widespread adoption and hindered the exploration of their full potential.
View Article and Find Full Text PDFThe Concept of Palliative Lymphaticovenular Anastomosis.
Lymphat Res Biol
January 2025
Department of Lymphedema Treatment Outpatient, Toyama Nishi General Hospital, Toyama, Japan.
Lymphaticovenular anastomosis (LVA) is the first-line surgical treatment for lymphedema. The therapeutic effects of LVA, including edema reduction and cellulitis prevention, vary among patients. We examined cases of palliative LVA in patients with lymphedema who were in the terminal stage due to recurrence or distant metastasis of the primary disease, with a focus on the course and usefulness of palliative LVA.
View Article and Find Full Text PDFRole of [18F]FDG-PET/CT in Evaluation of Tumor Response to Chemoradiation Therapy for Advanced Colorectal Cancer.
Indian J Nucl Med
November 2024
Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Objectives: The objective is to evaluate the efficacy of F-fluorodeoxyglucose positron emission tomography (F-FDG-PET) computed tomography (CT) in the evaluation of tumor response to preoperative/palliative chemoradiotherapy (CRT) for advanced colorectal cancer; including metastatic cancer at primary presentation and recurrent cancers with local and/or distant metastasis.
Materials And Methods: Fifty patients with advanced rectal cancer underwent two point imaging with 18 FDG PET-CT before and after 3 weeks of completion of preoperative/palliative CRT in between 2016 and 2022. Patients with locally recurrent cancer also underwent radical surgery.
Early identification of potentially reversible cancer cachexia using explainable machine learning driven by body weight dynamics: a multicenter cohort study.
Am J Clin Nutr
January 2025
Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China. Electronic address:
Background: Cachexia is associated with multiple adverse outcomes in cancer. However, clinical decision-making for oncology patients at the cachexia stage presents significant challenges.
Objective: This study aims to develop a machine learning (ML) model to identify potentially reversible cancer cachexia (PRCC).
PROshot: Hypofractionated Postmastectomy Radiation, Palliative Liver Radiation, Celiac Plexus Radiosurgery, Perioperative Chemoradiation for Gastric Cancer, and Prostate Stereotactic Body Radiation Therapy Versus Prostatectomy.
Pract Radiat Oncol
January 2025
Department of Radiation Oncology, Ascension St. Vincent's East, Birmingham, Alabama.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!